JP2022511995A5 - - Google Patents

Info

Publication number
JP2022511995A5
JP2022511995A5 JP2021542077A JP2021542077A JP2022511995A5 JP 2022511995 A5 JP2022511995 A5 JP 2022511995A5 JP 2021542077 A JP2021542077 A JP 2021542077A JP 2021542077 A JP2021542077 A JP 2021542077A JP 2022511995 A5 JP2022511995 A5 JP 2022511995A5
Authority
JP
Japan
Prior art keywords
seq
lys
dpr
repeat
peptide immunogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021542077A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022511995A (ja
JP7505788B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/053967 external-priority patent/WO2020072428A1/en
Publication of JP2022511995A publication Critical patent/JP2022511995A/ja
Publication of JP2022511995A5 publication Critical patent/JP2022511995A5/ja
Application granted granted Critical
Publication of JP7505788B2 publication Critical patent/JP7505788B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021542077A 2018-10-01 2019-10-01 C9orf72に由来するジペプチドリピートタンパク質に対して指向化されたペプチド免疫原コンストラクト Active JP7505788B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862739794P 2018-10-01 2018-10-01
US62/739,794 2018-10-01
PCT/US2019/053967 WO2020072428A1 (en) 2018-10-01 2019-10-01 Peptide immunogen constructs directed against dipeptide repeat proteins from c9orf72

Publications (3)

Publication Number Publication Date
JP2022511995A JP2022511995A (ja) 2022-02-01
JP2022511995A5 true JP2022511995A5 (cg-RX-API-DMAC7.html) 2022-10-05
JP7505788B2 JP7505788B2 (ja) 2024-06-25

Family

ID=70055826

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021542077A Active JP7505788B2 (ja) 2018-10-01 2019-10-01 C9orf72に由来するジペプチドリピートタンパク質に対して指向化されたペプチド免疫原コンストラクト

Country Status (8)

Country Link
US (1) US20210347866A1 (cg-RX-API-DMAC7.html)
EP (1) EP3861007A4 (cg-RX-API-DMAC7.html)
JP (1) JP7505788B2 (cg-RX-API-DMAC7.html)
CN (1) CN113227116A (cg-RX-API-DMAC7.html)
AU (1) AU2019354291A1 (cg-RX-API-DMAC7.html)
CA (1) CA3114657A1 (cg-RX-API-DMAC7.html)
TW (1) TWI781347B (cg-RX-API-DMAC7.html)
WO (1) WO2020072428A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018342105B2 (en) 2017-09-26 2023-11-16 University Of Florida Research Foundation, Incorporated Use of metformin and analogs thereof to reduce ran protein levels in the treatment of neurological disorders
US20230218730A1 (en) * 2019-09-23 2023-07-13 University Of Florida Research Foundation, Incorporated Vaccine therapy for ran protein diseases
WO2021072187A2 (en) 2019-10-10 2021-04-15 University Of Florida Research Foundation, Incorporated Ran proteins as biomarkers in cag/ctg expansion disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025468A (en) * 1998-06-20 2000-02-15 United Biomedical, Inc. Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides
US6906169B2 (en) * 2001-05-25 2005-06-14 United Biomedical, Inc. Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
GB0510763D0 (en) * 2005-05-27 2005-06-29 London School Hygiene & Tropical Medicine Malaria vaccines
RS59283B1 (sr) * 2013-01-22 2019-10-31 Deutsches Zentrum Fuer Neurodegenerative Erkrankungen E V Proteini sa dipeptidnim ponovkom kao terapeutsko ciljno mesto kod neurodegenerativnih bolesti sa ekspanzijom heksanukleotidnog ponovka
WO2014116865A1 (en) * 2013-01-24 2014-07-31 Mayo Foundation For Medical Education And Research Methods and materials for detecting c9orf72 hexanucleotide repeat expansion positive frontotemporal lobar degeneration or c9orf72 hexanucleotide repeat expansion positive amyotrophic lateral sclerosis
US9102752B2 (en) 2013-03-15 2015-08-11 United Biomedical, Inc. Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type
MY192689A (en) * 2013-10-11 2022-09-01 Ionis Pharmaceuticals Inc Compositions for modulating c9orf72 expression
CA2960925A1 (en) 2014-09-30 2016-04-07 Neurimmune Holding Ag Human-derived anti-dipeptide repeats (dprs) antibody

Similar Documents

Publication Publication Date Title
JP5829830B2 (ja) E型肝炎ウイルスのポリペプチド断片、それを含むワクチン組成物及び診断キット、並びにその使用
Rubio et al. Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20–38) peptide displayed on bacterial thioredoxin
JP2009067810A (ja) 合成ペプチドとそれを含むワクチン
CN1609617B (zh) 诊断与预防严重急性呼吸道综合症(sars)的组合物和方法
JP2006504653A5 (cg-RX-API-DMAC7.html)
JP2003529319A (ja) HIV−1gp41を標的化する広範に中和する抗体を誘発する方法
SK7602001A3 (en) Hbv core antigen particles with multiple immunogenic components attached via peptide ligands
JPH06169781A (ja) Hpv‐16 e6およびe7‐遺伝子由来ペプチドの、診断のための使用
JP2006505502A5 (cg-RX-API-DMAC7.html)
CN106232813B (zh) 预防减蛋综合征(eds)的疫苗
JPH05262667A (ja) ウイルス抗原を用いるワクチン
KR20190056382A (ko) 안정화된 그룹 2 인플루엔자 헤마글루티닌 줄기 영역 삼량체 및 그의 용도
EA022788B1 (ru) Новые терапевтические и диагностические средства
CN114276422B (zh) 新型冠状病毒s蛋白多肽抗原及其应用
TW202308685A (zh) 冠狀病毒和流感病毒組合物及其使用方法
JPH02503916A (ja) Hivエンベロープ蛋白質に関連する合成ペプチド
JP2006519160A5 (cg-RX-API-DMAC7.html)
JP2022511995A (ja) C9orf72に由来するジペプチドリピートタンパク質に対して指向化されたペプチド免疫原コンストラクト
KR20100139096A (ko) 조성물, 방법 및 키트
CN113943349A (zh) 靶向识别抗新冠病毒中和抗体N-IgY-pAbs的核心氨基酸序列组及应用
DK200800635A (da) Hidtil ukendt fiskelusvaccine.
CN120390752A (zh) 靶向具有半胱天冬酶激活和募集结构域(asc)的凋亡相关斑点样蛋白的组合物及使用方法
CN100467485C (zh) Sars冠状病毒相关多肽及其应用
CN115850398A (zh) 新型冠状病毒奥密克戎系列变异株的多肽组合物及其应用
JP2024518548A (ja) アミノ酸、ヌクレオチドおよびそれを発現するベクター、ならびにサルベコウイルス感染症の予防におけるそれらの使用